|
|
||||||||
Institute of Nutritional Sciences, University of Giessen, 35392 Giessen, Germany
| |
ABSTRACT |
|---|
|
|
|---|
The reabsorption of filtered di- and
tripeptides as well as certain peptide mimetics from the tubular lumen
into renal epithelial cells is mediated by an
H+-coupled
high-affinity transport process. Here we demonstrate for the first time
H+-coupled uptake of dipeptides
into the renal proximal tubule cell line
LLC-PK1. Transport was assessed
1) by uptake studies using the
radiolabeled dipeptide
D-[3H]Phe-L-Ala,
2) by cellular accumulation of the fluorescent dipeptide D-Ala-Lys-AMCA, and
3) by measurement of intracellular
pH (pHi) changes as a
consequence of H+-coupled
dipeptide transport. Uptake of
D-Phe-L-Ala
increased linearly over 11 days postconfluency and showed all the
characteristics of the kidney cortex high-affinity peptide transporter,
e.g., a pH optimum for transport of
D-Phe-L-Ala
of 6.0, an apparent Km value for
influx of 25.8 ± 3.6 µM, and affinities of differently charged
dipeptides or the
-lactam antibiotic cefadroxil to the binding site
in the range of 20-80 µM.
pHi measurements established the
peptide transporter to induce pronounced intracellular acidification in
LLC-PK1 cells and confirm its
postulated role as a cellular acid loader.
PEPT2; proximal tubule cell line LLC-PK1; intracellular acidification; kinetic characterization
| |
INTRODUCTION |
|---|
|
|
|---|
PEPTIDE TRANSPORTERS located in the brush-border
membrane of kidney tubular cells play a pivotal role in preserving
amino acid nitrogen by reabsorption of di- and tripeptides filtered or
generated by enzymatic hydrolysis of larger filtered oligopeptides. Two
peptide transport systems with different substrate affinities have been
described to exist in the brush-border membrane of the tubular cells
(9, 10, 23). Both systems were found to operate in an electrogenic mode
by coupling of substrate influx to an inwardly directed
H+ gradient (9, 23, 26, 27).
Besides short-chain peptides, a number of peptidomimetics carrying a
peptide backbone, such as
-lactam antibiotics of the
aminocephalosporin class or the anti-cancer agent bestatin, serve as
substrates (8, 15, 23). The cDNAs encoding the two distinctly different
H+-peptide cotransporters have
been cloned from intestine (PEPT1) and kidney (PEPT2) of
various species (3, 4, 13, 19, 20, 22, 25). Although the high-affinity
transporter PEPT2 is expressed mainly in the kidney but not in the gut
(3, 20, 25), PEPT1 mRNA is also expressed at low levels in renal tissue (19, 20, 22).
Although the characterization of the renal high-affinity transporter has been performed after heterologous expression (1, 3), a detailed analysis of its function in renal epithelial cells with regard to kinetics and acid-loading mechanisms has not been performed. This lack of information results mainly from the unavailability of suitable cell lines. Until now, the only cell line described to express the kidney-specific high-affinity H+-peptide cotransporter endogenously is SKPT-0193 Cl.2 obtained by SV40 transformation of rat proximal tubular cells (6). In the present study we describe for the first time the endogenous expression of a high-affinity peptide transporter in the porcine kidney cell line LLC-PK1. Because LLC-PK1 cells have been shown to differentiate into epithelial cells that have been proven to be useful in the study of selected proximal cell processes (21, 31), they might provide a valuable model for studies on the characteristics and regulation of the renal high-affinity peptide transporter.
| |
METHODS |
|---|
|
|
|---|
Materials. Custom-synthesized
D-[3H]Phe-L-Ala (9 Ci/mmol) and unlabeled
D-Phe-L-Ala
were obtained from Zeneca (Cheshire, UK) and Bachem (Heidelberg,
Germany), respectively. All other peptides and
-lactams were
purchased from Sigma Chemical. The pH-sensitive fluorescent dye
2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein-AM (BCECF-AM) was obtained from Bioprobes (Leiden, Netherlands). Fluorescent N-hydroxy-succinimidyl
7-amino-4-methylcoumarin-3-acetic acid (AMCA-NHS) was obtained from
Pierce (Rockford, IL). All the materials needed for cell culture were
either from GIBCO (Eggenstein, Germany) or Renner (Dannstadt, Germany).
Rat tail collagen R was purchased from Serva. All reagents for RNA
preparation and RT-PCR were from MBI Fermentas (Heidelberg, Germany),
and the primers were custom synthesized by Eurogentec (Seraing,
Belgium). Tertiary butyl-oxy-carbonyl-D-Ala-L-Lys-tertiary
butylester
(Boc-D-Ala-L-Lys-OtBu) was a generous gift from Prof. H. Brückner (Giessen, Germany).
Cell culture. LLC-PK1 cells (American Type Culture Collection, CRL 1392, passage 195) were cultured and passaged in Dulbecco's modified Eagle's medium (GIBCO 41965) supplemented with 10% fetal calf serum, 2 mM glutamine, 1% MEM nonessential amino acids (GIBCO 01140), 10 mM HEPES, 1 mM sodium pyruvate, 100 IU/ml penicillin, and 100 µg/ml streptomycin in a humidified incubator at 37°C under an atmosphere of 5% CO2. Cells between passages 200 and 215 were seeded at a density of 5 × 105 cells/well on Renner 6-well plastic cell culture plates or 2.2 × 105 cells/well on 12-well plates subsequent to collagen coating of the wells with rat tail collagen.
Transport studies. Flux studies in
LLC-PK1 cells were performed in a
buffer containing (in mM) 145 NaCl, 5.4 Cl, 1.8 CaCl2, 1.8 MgSO4, 20 glucose, and 25 HEPES/Tris (pH 7.4) or MES/Tris (pH
6.5), respectively. For uptake,
cell monolayers grown in six-well plates were washed free of
serum-containing medium and incubated with substrates or inhibitors for
15 min at 37°C. After the incubation period the cells were washed
three times with ice-cold incubation buffer, scraped off with a rubber
policeman after addition of 600 µl TEN buffer/well (in mM: 150 NaCl,
40 Tris, 1 EDTA), and digested with 20 µl of tissue solubilizer.
Cellular accumulation of
D-[3H]Phe-L-Ala was
measured subsequent to the addition of scintillation cocktail by liquid
scintillation spectroscopy. Binding of tracer to the cells was
determined as the residual radioactivity associated with the cells in
the presence of excess nonlabeled (20 mM) Gly-Gln. Uptake of
D-[3H]Phe-L-Ala over 15 min was linear for all pH values and substrate concentrations tested.
Synthesis of
D-Ala-L-Lys-AMCA
and fluorescence microscopy.
Conjugation of AMCA with the
-amino group of lysine has been carried
out using
Boc-D-Ala-L-Lys-OtBu
and AMCA-NHS as starter molecules (2). After removal of protective
groups,
D-Ala-L-Lys-AMCA was purified by two-dimensional preparative thin-layer chromatography. Determination of the compound's concentration was based on its molar
extinction coefficient (absorption maximum at 340 nm) and fluorescent
properties (emission maximum at 450 nm when excited at 340 nm).
RT-PCR from RNA of LLC-PK1 cells. RNA from LLC-PK1 cells was isolated by using the Tristar RNA-clean kit from MBI Fermentas (Heidelberg, Germany). RT-PCR was performed with 5 µg of isolated RNA. First-strand cDNA synthesis was accomplished with a primer representing nucleotides 1899-1879 (back primer: 5'-CCTGTGACAGAGAACATGACC-3') of the protein-coding region of rabbit PEPT2. PCR amplification of a 732-bp product was achieved with a forward primer, representing nucleotides 1167-1188 (5'-CTAGCATGCCTG GCATTTGCAG-3') of the rabbit PEPT2 protein-coding region, and the back primer. Amplification was performed with 35 cycles (95°C denaturation for 1 min, 55°C hybridization for 2 min, 72°C extensions for 2 min; Personal Cycler; Biometra, Göttingen, Germany). RT-PCR products were separated on a 1% agrose gel and visualized by ethidium bromide.
Calculations and statistics. All calculations (linear as well as nonlinear regression analysis) were performed by using Prism 2.01 (Graph PAD, Los Angeles, CA). For each variable, three to nine independent experiments were carried out. Data are means ± SE. Significance of differences between control and treated cells was determined by a nonpaired t-test.| |
RESULTS |
|---|
|
|
|---|
Uptake of D-[3H]Phe-L-Ala and D-Ala-L-Lys-AMCA into LLC-PK1 cells in the postconfluent state. Peptide transport into LLC-PK1 cells was measured by uptake of radiolabeled D-Phe-L-Ala at various time points after the cells had reached confluency. Although LLC-PK1 cells have been described not to possess substantial peptide transport activity on the day of reaching confluency (7), uptake of D-[3H]Phe-L-Ala at pH 6.0 increased almost linearly for up to 11 days in the postconfluent state (Fig. 1). Moreover, transport rates were suppressed to rates similar to that of confluent cells (0 days) by the addition of 1 mM Gly-Gln (Fig. 1). All further uptake experiments were performed at day 9 of postconfluency, since cell adherence to the culture wells decreased subsequent to this time point. The uptake of dipeptides or dipeptide mimetics into LLC-PK1 cells in the postconfluent state was also demonstrated by transport studies, using the fluorescent dipeptide D-Ala-L-Lys-AMCA as a substrate. Although cells displayed a bright blue fluorescence when incubated with the fluorophore-conjugated dipeptide, simultaneous application of 5 mM Gly-Gln reduced staining of the cells to background levels (Fig. 2).
|
|
Characteristics of
D-[3H]Phe-L-Ala influx
into LLC-PK1 cells.
Transport of D-Phe-L-Ala into
LLC-PK1 cells as a function of apical pH increased fourfold
when buffer pH values were reduced from 7.4 to 6.0 (Fig.
3, inset). At pH values
<5.5, transport rates were moderately reduced when compared with the
transport optimum at pH 6.0-5.5. Uptake of
D-Phe-L-Ala as a function of substrate
concentration followed Michaelis-Menten kinetics with an apparent
Michaelis-Menten constant
(Km) of 25.8 ± 3.6 µM and a maximum velocity
(Vmax) of 33.4 ± 1.7 pmol · cm
2 · 15 min
1 (Fig. 3).
The kinetic characteristics of
D-Phe-Ala influx into LLC-PK1 cells therefore closely
resemble those found for the same substrate when assessed in
Xenopus oocytes expressing the cloned renal PEPT2 transporter (11).
|
-lactam antibiotic cefadroxil. In contrast, benzylpenicillin, another
-lactam, failed to reduce transport. Moreover, captopril, an angiotensin-converting enzyme inhibitor that has been demonstrated to
interact with PEPT1 (4) but not with PEPT2 (3), was also unable to
inhibit
D-Phe-L-Ala
influx into LLC-PK1 cells. The
high-affinity phenotype interaction of cefadroxil with the transporter
was confirmed by its dose-dependent inhibition with an apparent
Ki value of 15.2 ± 1.1 µM (Fig. 4). Cefadroxil uptake
in oocytes mediated by the cloned PEPT2 (3) occurs with a
Km of 25.8 ± 6.3 µM but showed an
~30-fold lower affinity when studied with the cloned intestinal
isoform PEPT1 (4). In addition, the apparent
Ki values of
three differently charged dipeptides (Gly-Gln, Gly-Asp, Gly-Lys) were
determined. This was of interest since we recently demonstrated for
PEPT2, when expressed in oocytes, that affinities for the peptides
decreased in the order Gly-Asp, Gly-Gln, Gly-Lys (1). From Fig. 4 it
becomes evident that all substrates displayed a high affinity to the
binding site of the peptide transporter in
LLC-PK1 cells. Moreover,
affinities of the differently charged dipeptides clearly revealed
PEPT2-like characteristics with
Ki values of
8.0 ± 1.3 µM for Gly-Asp, 30.3 ± 1.2 µM for
Gly-Gln, and 151.8 ± 1.4 µM for Gly-Lys, respectively.
|
|
Intracellular acidification of LLC-PK1 cells as a consequence of H+-peptide cotransport. H+-coupled peptide transport with a concomitant decline in pHi has so far been demonstrated for the renal transporter only for the acidic substrate Ala-Asp (17).
By using the pHi indicator BCECF, here we show that superfusion of LLC-PK1 cells with acidic (Gly-Asp), neutral (Gly-Gln), or basic (Gly-Lys) dipeptides at extracellular pH 6.0 leads to strong intracellular acidification that reached steady-state levels at a pHi of 6.25 and did not differ significantly between those peptides chosen (Fig. 5). In contrast, the acidification induced by cefadroxil was markedly smaller (Fig. 5). After the substrates were washed out by perfusion with buffer pH 7.4, cells totally recovered from the peptide or peptide mimetic-induced acid load, and pHi returned to its initial values.
|
Expression of a PEPT2 isoform in LLC-PK1 cells. Although the functional data obtained suggested that the transporter expressed in LLC-PK1 cells is PEPT2-like, the porcine transporter has not been cloned, and therefore it is not known whether the transporter is expressed in these cells. We therefore performed RT-PCR analysis with specific primers derived from highly conserved regions of cloned PEPT2. It becomes evident from Fig. 6 that a product of 732 bp (specific for PEPT2 but not PEPT1) was amplified from LLC-PK1 RNA samples. In addition, the amplified product revealed the same EcoR V restriction site as rabbit PEPT2, suggesting that at least a very similar gene product is expressed in LLC-PK1 cells.
|
| |
DISCUSSION |
|---|
|
|
|---|
Reabsorption of short-chain peptides in the mammalian renal tubule has been described as mediated by two different H+-coupled transport systems that differ considerably in substrate affinities (9, 10, 23). Although the high-affinity-type transport system PEPT2 is prominent on the mRNA level and the functional level, Northern blot analysis suggested that the mRNA of the low-affinity-type transporter PEPT1 is also expressed in kidney but at low levels (19, 20, 22). Brandsch et al. (6) suggested that PEPT1 and PEPT2 may be located in different sections of the nephron. According to their hypothesis, the concentration of small peptides increases from proximal to distal parts of the nephron, due to progressive hydrolysis of filtered oligopeptides by brush-border membrane peptidases. Therefore, the presence of the high-affinity-type PEPT2 in more proximal and of the low-affinity-type PEPT1 in more distal parts of the tubule would be advantageous with regard to the most efficient conservation of amino acid nitrogen. However, so far the proposed different localizations of both transporter isoforms along the tubule, e.g., by in situ hybridization techniques or immunolocalization, have not been reported.
Madin-Darby canine kidney cells, which display characteristics of cells of the distal tubule (18) or collecting duct (24), have been demonstrated to express a low-affinity-type peptide (PEPT1-like) transport activity, suggesting that distal parts of the tubule express solely functional PEPT1 carriers. Moreover, it was shown that this transporter activity is regulated by calmodulin-dependent processes (7).
Although, recently, expression of the high-affinity PEPT2 transporter in rat proximal tubular cells immortalized by SV40 transformation (6) has been demonstrated, these cells are not readily available. The well-established renal proximal cell line LLC-PK1 (16, 21, 28), on the other hand, was reported not to possess endogenous peptide transport activity (7, 29, 30), a feature that was exploited to use LLC-PK1 as a host for heterologous expression of PEPT1 and PEPT2 (29-31). Confirming the results of these studies, it was shown here that, before reaching the confluent state, LLC-PK1 cells possess indeed only very low peptide transport activity. However, we also clearly demonstrate that endogenous peptide transport activity resembling the PEPT2 type is expressed in LLC-PK1 after cells have reached confluency. Phenotypical characteristics of PEPT2, such as the pH optimum for D-[3H]Phe-L-Ala influx, the kinetics of dipeptide influx, and the existence of a PEPT2-specific mRNA present in LLC-PK1 cells, justify this conclusion. In addition, the apparent affinities for dipeptides and cefadroxil determined in LLC-PK1 are almost identical to those reported in Xenopus laevis oocytes (3, 11) or Pichia pastoris (12) expressing the cloned rabbit renal PEPT2 or in Hela cells expressing the human PEPT2 (14). Affinities of the same substrates for interaction with the intestinal transporter are >20-fold lower when determined in oocytes expressing PEPT1 (4, 11). In the postconfluent state LLC-PK1 cells not only transport D-[3H]Phe-L-Ala but also the dipeptide mimetic D-Ala-L-Lys-AMCA. This fluorescent dipeptide has recently been demonstrated to display influx characteristics in PEPT2-expressing P. pastoris that were almost identical to those obtained by use of radiolabeled D-Phe-L-Ala (12). The coumarin-conjugated dipeptide therefore might allow investigators to study peptide transport in LLC-PK1 cells independently of expensive custom synthesis of radiolabeled substrates.
Although the pH dependency of dipeptide transport and the rheogenic
character of PEPT2-mediated influx of neutral dipeptides already
suggested that H+ is the cotransported ion species, this
had been verified experimentally in renal cells only for Ala-Asp (17).
Here we show that translocation of peptide substrates is associated
with H+ influx that reduces
pHi markedly, irrespective of the
net charge of the substrates. By using the
pHi indicator BCECF, we
demonstrate that intracellular acidification rates following perfusion
with Gly-Asp, Gly-Gln, and Gly-Lys are very similar, whereas those generated by the
-lactam cefadroxil are significantly lower. When
currents associated with transport of Gly-Asp, Gly-Gln, and Gly-Lys
were determined in voltage-clamped oocytes expressing the rabbit PEPT2,
we observed that the same three substrates generated the same maximal
current responses, independently of the net charge of the substrates at
extracellular pH 6.5 (1). Although
pHi could not be measured in
oocytes expressing PEPT2, we suggested that the different dipeptides
were transported by the same
peptide-H+ flux-coupling ratio and
that this is the consequence of transport of only the zwitterionic form
of the substrates. Our present findings in
LLC-PK1 cells confirm this
hypothesis by almost identical intracellular acidification rates in the
presence of the three differently charged peptides, which may also
result from similar if not identical flux-coupling ratios and maximal
transport rates.
That pHi is more reduced by
dipeptides than by cefadroxil suggests a higher maximal transport
capacity for dipeptides. This may be a consequence of the
configuration, e.g., when peptides consisting of
L-amino acids are compared with
substrates with a
D-configuration in the
amino-terminal position, such as in cefadroxil or
D-Phe-L-Ala.
This hypothesis is supported by the fact that pHi changes induced by
D-Phe-L-Ala
are comparable with those of cefadroxil but smaller than those induced
by dipeptides consisting of
L-amino acids only (data not
shown). However, it needs to be emphasized that a rapid intracellular
hydrolysis of the dipeptides consisting of
L-
-amino acids could also
contribute to the more pronounced decrease in
pHi observed for the natural dipeptides.
The demonstration that pHi is markedly reduced when dipeptides are taken up by the renal peptide transporter addresses the physiological importance of these transport-mediated pHi changes. Because di- and tripeptides are present in plasma and are continuously filtered in the glomerulus, the renal peptide transporter operates as a constant acid loader in tubular cells. This is important for both the pHi recovery systems and their regulation, as well as for other metabolic events such as increased renal ammoniagenesis in response to a low pHi. Because a number of protein kinase recognition sites have been identified in the coding sequence of PEPT2, regulation of transport activity, in particular in relation to changes in pHi, needs to be investigated. For this purpose LLC-PK1 might provide a very useful cellular model.
| |
ACKNOWLEDGEMENTS |
|---|
We gratefully acknowledge Prof. Dr. H. Brückner (University of Giessen, Germany) for supplying Boc-D-Ala-L-Lys-OtBu.
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: H. Daniel, Institute of Nutritional Sciences, Wilhelmstr. 20, 35392 Giessen, Germany.
Received 15 June 1998; accepted in final form 21 August 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Amasheh, S.,
U. Wenzel,
W.-M. Weber,
W. Clauss,
and
H. Daniel.
Electrophysiological analysis of the function of the mammalian renal peptide transporter expressed in Xenopus laevis oocytes.
J. Physiol. (Lond.)
504:
169-174,
1997[Medline].
2.
Anderson, G. W.,
J. E. Zimmermann,
and
F. M. Callahan.
N-hydroxy-succinimide esters in peptide synthesis.
J. Am. Soc.
86:
1839-1849,
1963.
3.
Boll, M.,
M. Herget,
M. Wagener,
W.-M. Weber,
D. Markovich,
J. Biber,
W. Clauss,
H. Murer,
and
H. Daniel.
Expression cloning and functional characterization of the kidney cortex high-affinity proton-coupled peptide transporter.
Proc. Natl. Acad. Sci. USA
93:
284-289,
1996
4.
Boll, M.,
D. Markovich,
W.-M. Weber,
H. Korte,
H. Daniel,
and
H. Murer.
Expression cloning of a cDNA from rabbit small intestine related to proton-coupled transport of peptides,
-lactam antibiotics and ACE-inhibitors.
Pflügers Arch.
429:
146-149,
1994[Medline].
5.
Boyarski, G.,
C. Hanssen,
and
L. Clyne.
Superiority of in vitro over in vivo calibrations of BCECF in vascular smooth muscle cells.
FASEB J.
10:
1205-1212,
1996[Abstract].
6.
Brandsch, M.,
C. Brandsch,
P. D. Prasad,
V. Ganapathy,
U. Hopfer,
and
F. H. Leibach.
Identification of a renal cell line that constitutively expresses the kidney-specific high-affinity H+/peptide cotransporter.
FASEB J.
9:
1489-1496,
1995[Abstract].
7.
Brandsch, M.,
V. Ganapathy,
and
F. H. Leibach.
H+-peptide cotransport in Madin-Darby canine kidney cells: expression and calmodulin-dependent regulation.
Am. J. Physiol.
268 (Renal Fluid Electrolyte Physiol. 37):
F391-F397,
1995
8.
Daniel, H.,
and
S. A. Adibi.
Transport of
-lactam antibiotics in kidney brush border membrane.
J. Clin. Invest.
92:
2215-2223,
1993.
9.
Daniel, H.,
E. L. Morse,
and
S. A. Adibi.
The high and low affinity transport systems for dipeptides in kidney brush border membrane respond differently to alterations in pH gradient and membrane potential.
J. Biol. Chem.
266:
19917-19924,
1991
10.
Daniel, H.,
E. L. Morse,
and
S. A. Adibi.
Determinants of substrate affinity for the oligopeptide/H+ symporter in the renal brush border membrane.
J. Biol. Chem.
267:
9565-9573,
1992
11.
Döring, F.,
D. Dorn,
U. Bachfischer,
S. Amasheh,
M. Herget,
and
H. Daniel.
Functional analysis of a chimeric mammalian peptide transporter derived from the intestinal and renal isoforms.
J. Physiol. (Lond.)
497:
773-779,
1996[Medline].
12.
Döring, F.,
T. Michel,
A. Rösel,
M. Nickolaus,
and
H. Daniel.
Expression of the mammalian renal peptide transporter PEPT2 in the yeast Pichia pastoris and applications of the yeast system for functional analysis.
Mol. Membr. Biol.
15:
79-88,
1998[Medline].
13.
Fei, Y.-J.,
Y. Kanai,
S. Nussberger,
V. Ganapathy,
F. H. Leibach,
M. F. Romero,
S. K. Singh,
W. F. Boron,
and
M. A. Hediger.
Expression cloning of a mammalian proton-coupled oligopeptide transporter.
Nature
368:
563-566,
1994[Medline].
14.
Ganapathy, M. E.,
M. Brandsch,
P. D. Prasad,
V. Ganapathy,
and
F. H. Leibach.
Differential recognition of beta-lactam antibiotics by intestinal and renal peptide transporters, PEPT1 and PEPT2.
J. Biol. Chem.
270:
25672-25677,
1995
15.
Hori, R.,
Y. Tomita,
T. Katsura,
M. Yasuhara,
K.-I. Inui,
and
M. Takano.
Transport of bestatin in rat renal brush-border membrane vesicles.
Biochem. Pharmacol.
45:
1763-1768,
1993[Medline].
16.
Hull, R. N.,
W. R. Cherry,
and
G. W. Weaver.
The origin and characteristics of a pig kidney cell strain, LLC-PK1.
In Vitro
12:
670-677,
1976[Medline].
17.
Jin, W.,
and
U. Hopfer.
Dipeptide-induced Cl
secretion in proximal tubule cells.
Am. J. Physiol.
273 (Cell Physiol. 42):
C1623-C1631,
1997
18.
Kersting, U.,
A. Schwab,
M. Treidtel,
W. Pfaller,
G. Gstraunthaler,
W. Steigner,
and
H. Oberleithner.
Differentiation of Madin-Darby canine kidney cells depends on cell culture conditions.
Cell. Physiol. Biochem.
3:
42-55,
1993.
19.
Liang, R.,
Y.-J. Fei,
P. D. Prasad,
S. Ramamoorthy,
H. Han,
T. L. Yang-Feng,
M. A. Hediger,
V. Ganapathy,
and
F. H. Leibach.
Human intestinal H+/peptide cotransporter.
J. Biol. Chem.
270:
6456-6463,
1995
20.
Liu, W.,
R. Liang,
S. Ramamoorthy,
Y.-J. Fei,
M. E. Ganapathy,
M. A. Hediger,
V. Ganapathy,
and
F. H. Leibach.
Molecular cloning of PepT2, a new member of the H+/peptide cotransporter family, from human kidney.
Biochim. Biophys. Acta
1235:
461-466,
1995[Medline].
21.
Malmström, K.,
and
H. Murer.
Parathyroid hormone inhibits phosphate transport in OK cells but not in LLC-PK1 and JTC-12.P3 cells.
Am. J. Physiol.
251 (Cell Physiol. 20):
C23-C31,
1986
22.
Miyamoto, K.-I.,
T. Shiraga,
K. Morita,
H. Yamamoto,
H. Haga,
Y. Taketani,
I. Tamai,
Y. Sai,
A. Tsuji,
and
E. Takeda.
Sequence, tissue distribution and developmental changes in rat intestinal oligopeptide transporter.
Biochim. Biophys. Acta
1305:
34-38,
1996[Medline].
23.
Ries, M.,
U. Wenzel,
and
H. Daniel.
Transport of cefadroxil in rat kidney brush-border membranes is mediated by two electrogenic H+-coupled systems.
J. Pharmacol. Exp. Ther.
271:
1327-1333,
1994
24.
Rindler, M. J.,
L. M. Chuman,
L. Shaffer,
and
M. H. Saier.
Retention of differentiated properties in an established dog kidney epithelial cell line (MDCK).
J. Cell Biol.
81:
635-648,
1981
25.
Saito, H.,
T. Terada,
M. Okuda,
S. Sasaki,
and
K.-I. Inui.
Molecular cloning and tissue distribution of rat peptide transporter PEPT2.
Biochim. Biophys. Acta
1280:
173-177,
1996[Medline].
26.
Silbernagl, S.,
V. Ganapathy,
and
F. H. Leibach.
H+ gradient-driven dipeptide reabsorption in proximal tubule of rat kidney. Studies in vivo and in vitro.
Am. J. Physiol.
253 (Renal Fluid Electrolyte Physiol. 22):
F448-F457,
1987
27.
Skopicki, H. A.,
K. Fisher,
D. Zikos,
R. Bloch,
G. Flouret,
and
D. R. Peters.
Multiple carriers for dipeptide transport: carrier mediated transport of glycyl-L-proline in renal BBMV.
Am. J. Physiol.
261 (Renal Fluid Electrolyte Physiol. 30):
F670-F678,
1991
28.
States, B.,
D. Harris,
and
S. Segal.
Differences between OK and LLC-PK1 cells: cystine handling.
Am. J. Physiol.
261 (Cell Physiol. 30):
C8-C16,
1991
29.
Terada, T.,
H. Saito,
M. Mukai,
and
K.-I. Inui.
Identification of the histidine residues involved in substrate recognition by a rat H+/peptide cotransporter, PEPT1.
FEBS Lett.
394:
196-200,
1996[Medline].
30.
Terada, T.,
H. Saito,
M. Mukai,
and
K.-I. Inui.
Characterization of stably transfected kidney epithelial cell line expressing rat H+/peptide cotransporter PepT1: localization of PepT1 and transport of
-lactam antibiotics.
J. Pharmacol. Exp. Ther.
281:
1415-1421,
1997[Abstract].
31.
Terada, T.,
H. Saito,
M. Mukai,
and
K.-I. Inui.
Recognition of
-lactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLC-PK1 cells.
Am. J. Physiol.
273 (Renal Physiol. 42):
F706-F711,
1997
This article has been cited by other articles:
![]() |
S. A. Bravo, C. U. Nielsen, J. Amstrup, S. Frokjaer, and B. Brodin Epidermal growth factor decreases PEPT2 transport capacity and expression in the rat kidney proximal tubule cell line SKPT0193 cl.2 Am J Physiol Renal Physiol, February 1, 2004; 286(2): F385 - F393. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Knutter, I. Rubio-Aliaga, M. Boll, G. Hause, H. Daniel, K. Neubert, and M. Brandsch H+-peptide cotransport in the human bile duct epithelium cell line SK-ChA-1 Am J Physiol Gastrointest Liver Physiol, July 1, 2002; 283(1): G222 - G229. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Terada, K. Sawada, T. Ito, H. Saito, Y. Hashimoto, and K.-I. Inui Functional expression of novel peptide transporter in renal basolateral membranes Am J Physiol Renal Physiol, November 1, 2000; 279(5): F851 - F857. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |